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Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) are rare soft tissue tumors that arise from a peripheral nerve or
exhibit nerve sheath differentiation. Most of these tumors arise on the trunk, extremities, or head and neck regions;
they are very rarely located in the abdominal cavity. The patient was a 71-year-old man who was referred to our
hospital for a mass and pain in the right lower abdomen. Abdominal computed tomography revealed a large (9 ×
9 cm), well-circumscribed, lobulated, heterogeneously enhanced mass in the pelvis. Exploratory laparotomy
revealed a large mass in the greater omentum, and the tumor was completely excised. Histopathological analysis
revealed that the tumor was composed of spindle cells with high mitotic activity. On staining the tumor, positive
results were obtained for S-100 but negative results were obtained for c-kit, cluster of differentiation (CD)34, a-
smooth muscle actin, and desmin. These findings strongly supported a diagnosis of MPNST primarily arising from
the greater omentum. To the best of our knowledge, this is the first reported case of an MPNST arising from the
greater omentum. In this report, we have described the case of a patient with an MPNST arising from the greater
omentum and have discussed the clinical characteristics and management of MPNSTs.
Background
Primary solid omental tumors are rare and include var-
ious types of tumors such as gastrointestinal stromal
tumors (GIST), leiomyosarcomas, hemangiocytomas,
fibrosarcomas, leiomyomas, liposarcomas, desmoids
tumors, fibromas, mesotheliomas, and myosarcomas [1].
Although the pathological spectrum of primary omental
tumors is diverse, no report has yet been published on
malignant peripheral nerve sheath tumors (MPNSTs)
arising from the greater omentum.
In this report, we describe the extremely rare case of a
Japanese man who had an MPNST arising from the
greater omentum.
Case presentation
The patient was a 71-year-old man who was healthy by
birth and was admitted to our hospital with pain in the
right lower abdomen. Physical examination revealed a
large, firm, movable mass in the abdomen. The hemato-
logical tests, including those for the serum levels of
tumor markers such as carcinoembryonic antigen
(CEA), carbohydrate antig e n( C A )1 9 - 9 ,a n dC A 1 2 5 ,
yielded normal results. Abdominal computed tomogra-
phy (CT) revealed a large (approximately, 9 × 9 cm),
well-circumscribed, lobulated mass in the pelvis. The
central region of the mass appeared to have low density,
while the marginal region was well enhanced in the CT
scan (Figure 1A). CT/positron emission tomography
(PET) with
18F-fluorodeoxygluc o s e( F D G )s h o w e da
mass with increased FDG accumulation in the right
lower abdomen, without any evidence of distant metas-
tasis (Figure 1B). Evaluation of the gastrointestinal tract
d i dn o ty i e l da n yd e f i n i t er e s u l t s .T h eo r i g i no ft h e
tumor could not be clearly determined.
Exploratory laparotomy was performed under the
diagnosis of an intra-abdominal tumor of unknown ori-
gin. During laparotomy, it was observed that the tumor
arose from the greater omentum and was not connected
with the gastrointestinal tract (Figure 2). The tumor was
completely excised along with the greater omentum.
Gross pathological examination revealed that the
tumor was a whitish-grey oval mass, with a maximum
diameter of 9 cm (Figure 3). Microscopic examination
revealed spindle cells arranged in intersecting fascicles
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any medium, provided the original work is properly cited.and polygonal cells arranged in sheets grow infiltrating
(Figure 4A). The cellular nuclei were polygonal (bulky,
roundish, and irregular), and the mitotic activity was
150 mitoses per 50 high-power fields. Coagulative
necrosis and myxoid changes were observed in the
tumor. Immunohistochemical analysis of the tumor cells
yielded positive staining results for S-100 (Figure 4B)
but negative results for c-kit, a-smooth muscle actin (a-
SMA), desmin, and cluster of differentiation (CD)34
(Figure 4C-F). The morphology and immunoprofile of
the tumor strongly supported a diagnosis of MPNST.
After an uneventful postoperative course, the patient
was discharged on the ninth postoperative day. At 12
months after surgery, the patient was in good condition,
and no evidence of local recurrence or distant metas-
tases was noted.
Discussion
MPNSTs are rare soft tissue tumors that arise in proxi-
mity to large peripheral nerves and account for 3-10% of
Figure 1 Preoperative imaging findings. A) CT scan shows a large, well-circumscribed, lobulated mass in the pelvis. The central region of the
mass appears to have low density, while the marginal region is well enhanced. B) FDG-PET/CT shows a mass with increased FDG accumulation
in the right lower abdomen, without any evidence of distant metastasis.
Figure 2 The tumor arises from the greater omentum and is
not connected with the gastrointestinal tract.
Figure 3 Macroscopically, the tumor is whitish grey and is
relatively firm and solid.
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coined by the World Health organization (WHO) and is
defined as any tumor that arises from a peripheral nerve;
this term replaces previously used heterogeneous and
often confusing terminology, such as malignant schwan-
noma, malignant neurilemmoma, and neurofibrosar-
coma, for tumors of neurogenic origin and similar
biological behavior. These tumors arise from major or
minor peripheral nerve branches or from the sheath of
peripheral nerve fibers. Most of these tumors arise on the
trunk, extremities, or the head and neck region [4,5].
MPNSTs arising from the abdominal cavity are extremely
rare. Only a few cases of MPNSTs arising from the gas-
trointestinal tract have been reported [6,7], and to date,
no cases of MPNSTs arising from the greater omentum
have been reported in the literature. Although 4 cases of
“benign schwannoma” of the greater/lesser omentum
have been reported in earlier studies [8-11], high mitotic
activity, which indicates malignant potential, was noted
only in our patient. Therefore, to the best of our knowl-
edge, this is the first reported case of an MPNST arising
from the greater omentum.
The pathologic diagnosis of MPNST is facilitated by
features such as palisading arrangement, nuclear atypia,
bizarre giant cells, mitotic figures, and necrosis. These
tumors have morphological heterogeneity, and staining
analysis of such tumors reveals spindle cells with a fasci-
cular pattern [12]. Histological and immunohistochem-
ical markers specific for MPNSTs are not available. The
S 1 0 0p r o t e i ni st h ea n t i g e nm o s tc o m m o n l yu s e dt o
identify nerve sheath tumors of various types. However,
S100 protein immunoreactivity is detected in only 50-
60% of MPNSTs, and this protein is also expressed in a
range of other tissues and tumor types [13,14]. Different
markers are used to exclude other spindle cell tumors.
Desmin and a-SMA are used to exclude smooth muscle
tumors, and CD34 and CD117 (c-kit) are used to
exclude GIST [15]. In our case, the strong S-100 expres-
sion without expression of other immunohistochemical
markers indicated the presence of an MPNST.
To date, little is known about MPNSTs arising from
the abdominal cavity. Therefore, the prognosis of and
initial treatments for such tumors are uncertain. A
recently published study investigated the overall prog-
nostic factors and survival of patients with MPNSTs in
all locations [4,5]. The results of this study, which
involved patients with localized MPNSTs, suggested that
the disease-specific survival rate for MPNSTs was
around 50% at 5 years. Most clinical series reported that
tumor size was the most reliable independent prognostic
factor; larger tumor size was related with worse out-
come. Zou et al. reported that negative staining results
for S-100 were associated with prognosis when the
tumors were completely resected [5].
Survival appears to be related to complete tumor
resection. Therefore, complete surgical resection of the
tumor in patients with MPNSTs is of utmost impor-
tance for their treatment.
Figure 4 Microscopic analysis (A: hematoxylin-eosin (HE) stain; B, C, D, E, F: immunohistochemical analysis). A: Spindle cells arranged in
intersecting fascicles and polygonal cells arranged in sheets grow infiltrating. The cellular nuclei are polygonal (bulky, roundish, and irregular),
and the tumor cells show 150 mitoses per 50 high-power fields (HE stain; magnification, ×20). B, C, D, E, F: Immunohistochemical images show
positive staining of tumor cells for S-100 but negative staining for c-kit, a-SMA, desmin, and CD34. (B: S-100, C: c-kit, D: a-SMA, E: desmin, F:
CD34)
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radiotherapy have a positive impact on the survival of
patients with MPNSTs. The results of most case series
indicate limited benefits and high morbidity on using
adjuvant radiotherapy or chemotherapy. Despite aggres-
sive combined radiation and systemic chemotherapy, the
5-year survival rates for MPNSTs range from 35% to
50% [16,17]. The current recommendation is that this
therapy be reserved for recurrent tumors, suspected
residual microscopic disease, and high-grade tumors [7].
Although these data may only describe what is known
regarding the behavior of this tumor in other locations
of the body, we recommend wide excision of MPNSTs
with very close postoperative follow-up imaging.
Conclusion
MPNSTs arising from the greater omentum are extre-
mely rare. It is important to recognize that an abdom-
inal mass may be caused by an MPNST. MPNSTs
should be considered as a rare differential diagnosis for
a tumor in the greater omentum.
Because no definite microscopic criteria are available
for distinguishing between benign and malignant
tumors, radical excision is the treatment of choice for
MPNSTs, and prolonged follow-up is essential.
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